how long have glp 1 agonists been around Timeline of GLP-1 discovery and clinical development. (a) Key events in... GLP-1 Receptor Agonist Market Forecast

Allulose &amp

Here, we test whether GLP-1RAs alter alcohols peripheral pharmacokinetics as a potential mechanism of action for their alcohol intake suppressive effects

This 2-supplement stack restores hydration, protects muscle & bone, and supports steady energy all day

The global Obesity Medicines market reached $66 billion in list price sales value in 2025, according to IQVIAs ForecastLink, and is forecast to rise to $92 billion in 2026, before reaching between $105 billion and $200 billion by 2027 and beyond

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors.